My question leads from a concern raised by a constituent specifically about the supply of insulin to Britain in the event of a 'no deal' Brexit. He raised concerns following remarks made by the Medicines and Healthcare products Regulatory Agency's Sir Michael Rawlins, who warned on 30 July that insulin is not manufactured in Britain, all of it has to be imported and it cannot be transported like other prescription drugs because it's temperature controlled. I submitted a written question to the health secretary—to you—during the summer recess about this, asking what action you were taking, and the response was that you were in regular discussions with the UK Department of Health and you'd keep my office and Assembly Members updated. So, my question is: given the uncertainty that surrounds Brexit at the moment, have there been any significant developments on this matter since I asked my written question?